0001144204-19-044292.txt : 20190911
0001144204-19-044292.hdr.sgml : 20190911
20190911184826
ACCESSION NUMBER: 0001144204-19-044292
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190909
FILED AS OF DATE: 20190911
DATE AS OF CHANGE: 20190911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goel Shubh
CENTRAL INDEX KEY: 0001787942
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32295
FILM NUMBER: 191089245
MAIL ADDRESS:
STREET 1: 1100 MAXWELL, #522
CITY: HOBOKEN
STATE: NJ
ZIP: 07030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FENNEC PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001211583
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PO BOX 13628
STREET 2: 68 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: (919) 636-4530
MAIL ADDRESS:
STREET 1: PO BOX 13628
STREET 2: 68 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: FENNEC PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20140903
FORMER COMPANY:
FORMER CONFORMED NAME: ADHEREX TECHNOLOGIES INC
DATE OF NAME CHANGE: 20021223
4
1
tv529267_4.xml
OWNERSHIP DOCUMENT
X0306
4
2019-09-09
0
0001211583
FENNEC PHARMACEUTICALS INC.
FENC
0001787942
Goel Shubh
68 TW ALEXANDER DRIVE, PO BOX 13628
DURHAM
NC
27709
0
1
0
0
Chief Commercial Officer
Stock Option (right to buy)
4.74
2019-09-09
4
A
0
175000
0
A
2029-09-09
Common Shares
175000
175000
D
On September 9, 2019, Shubh Goel was granted an incentive stock option to purchase 175,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan.
1/3 of the shares subject to this option shall vest and may be exercised as of September 9, 2020 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of September 9, 2022 and thereafter, 100% of the total number of shares subject to this option shall be vested.
/s/ Goel Shubh, Chief Commercial Officer
2019-09-11